Publicación:
Impacto del suministro de vacunas contra COVID-19 sobre la letalidad por SARS-COV-2 en Colombia

Vista sencilla de ítem
dc.contributor.authorDíaz Pinzón, Jorge Enriquespa
dc.date.accessioned2021-03-08 00:00:00
dc.date.accessioned2022-06-29T19:39:27Z
dc.date.available2021-03-08 00:00:00
dc.date.available2022-06-29T19:39:27Z
dc.date.issued2021-03-08
dc.format.mimetypeapplication/pdfspa
dc.format.mimetypetext/htmlspa
dc.format.mimetypeapplication/epub+zipspa
dc.format.mimetypetext/xmlspa
dc.format.mimetypeaudio/mpegspa
dc.identifier.doi10.31260/RepertMedCir.01217372.1237
dc.identifier.eissn2462-991X
dc.identifier.issn0121-7372
dc.identifier.urihttps://repositorio.fucsalud.edu.co/handle/001/3067
dc.identifier.urlhttps://doi.org/10.31260/RepertMedCir.01217372.1237
dc.language.isospaspa
dc.publisherSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Saludspa
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1237/1592
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1237/1593
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1237/1594
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1237/1596
dc.relation.bitstreamhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1237/1595
dc.relation.citationedition: Vol. 30 Suplemento 2021spa
dc.relation.citationendpage50
dc.relation.citationstartpage46
dc.relation.ispartofjournalRevista Repertorio de Medicina y Cirugíaspa
dc.relation.referencesZhou P, Xing-Lou Y, Xian-Guang W, Ben H, Lei Z, Wei Z, Hao-Rui S, Yan Z, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273. doi: 10.1038/s41586-020-2012-7spa
dc.relation.referencesZhu N. Dingyu Z, Wenling W, Xingwang L, Bo Y, Jingdong S, Xiang Z, Baoying H, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi: 10.1056/NEJMoa2001017spa
dc.relation.referencesPan KY, Kok AA, Eikelenboom M, Horsfall M, Jörg F, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry. 2021;8(2):121-129. doi: 10.1016/S2215-0366(20)30491-0spa
dc.relation.referencesPierce M, Hope H, Ford T, Hatch S, Hotopf M, John A, et al. Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population. Lancet Psychiatry. 2020;7(10):883-892. doi: 10.1016/S2215-0366(20)30308-4spa
dc.relation.referencesMofijur M, Rizwanul Fattah IM, Asraful Alam Md, Saiful Islam ABM, Chyuan Ong H, et al. Impact of COVID-19 on the social, economic, environmental and energy domains: Lessons learnt from a global pandemic. Sustain Prod Consum. 2021;26:343-359. doi: 10.1016/j.spc.2020.10.016spa
dc.relation.referencesBaden LR, El Sahly HM, Essink B, Kotloff K, Frey S, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:403–416. doi: 10.1056/NEJMoa2035389spa
dc.relation.referencesVoysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1spa
dc.relation.referencesPolack FP, Stephen JT, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Gonzalo Pérez M. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-2615. doi: 10.1056/NEJMoa2034577spa
dc.relation.referencesWang J, Peng Y, Xu H, Cui Z, Williams RO. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech. 2020;21(6):225. doi: 10.1208/s12249-020-01744-7spa
dc.relation.referencesRawat K, Kumari P, Saha, L. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. Eur J Pharmacol. 2021;892:173751. doi: 10.1016/j.ejphar.2020.173751spa
dc.relation.referencesAbbasi K. Behavioural fatigue: a flawed idea central to a flawed pandemic response. BMJ. 2020;370:m3093. doi: 10.1136/bmj.m3093spa
dc.relation.referencesRypdal K, Bianchi FM, Rypdal, M. Intervention Fatigue is the Primary Cause of Strong Secondary Waves in the COVID-19 Pandemic. Int J Environ Res Public Health. 2020;17(24):9592. doi: 10.3390/ijerph17249592spa
dc.relation.referencesPriesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T, et al. Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections. Lancet. 2021;397(10269):92-93. doi: 10.1016/S0140-6736(20)32625-8spa
dc.relation.referencesPriesemann V, Balling R, Brinkmann MM, Ciesek S, Czypionka T, et al. An action plan for pan-European defence against new SARS-CoV-2 variants. Lancet. 2021;397(10273):469-470. doi: 10.1016/S0140-6736(21)00150-1spa
dc.relation.referencesDavies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):eabg3055. doi: 10.1126/science.abg3055spa
dc.relation.referencesAbbott S, Funk S, CMMID COVID-19 Working Group. Local area reproduction numbers and S-gene target failure [Internet]. Centre for Mathematical Modelling of Infectious Diseases 2021. [Citado 10 de junio de 2021]; Disponible en: https://cmmid.github.io/topics/covid19/local-r-sgtf.htmlspa
dc.relation.referencesHorby P, Huntley C, Davies N, Edmunds J, Ferguson N, Medley G, Semple C. NERVTAG paper on COVID-19 variant of concern B.1.1.7. Department of Health and Social Care. [Citado 10 de junio de 2021]; Disponible en: https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-variant-of-concern-b117spa
dc.relation.referencesBubar, KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. medRxiv. 2020;2020.09.08.20190629. doi: 10.1101/2020.09.08.20190629.spa
dc.relation.referencesRamos AM, Vela-Pérez M, Ferrández MR, Kubik AB, Ivorra B. Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19. Preprint in ResearchGate. [Citado 10 de junio de 2021]; Disponible en: https://doi.org/10.13140/RG.2.2.32580.24967/2spa
dc.relation.referencesSuárez-Ibujes M. Coeficiente de correlación de Karl Pearson [Internet]. 2021. [citado 14 mayo 2021]; Disponible en: https://www.monografias.com/trabajos85/coeficiente-correlacion-karl-pearson/coeficiente-correlacion-karl-pearson.shtmlspa
dc.relation.referencesMoreno-Altamirano A. López-Moreno S, Corcho-Berdugo A. Principales medidas en epidemiología. Salud Pública de México. 2000;42(4):337-348.spa
dc.relation.referencesQuintana-Salgado L. Medidas de frecuencia en epidemiología [Internet]. 2015. [Citado 10 de junio de 2021]; Disponible en: https://es.slideshare.net/lualberts20/medidas-de-frecuencia-en-epidemiologa-2015spa
dc.relation.referencesDíaz Pinzón JE. Estimación de las tasas de mortalidad y letalidad por COVID-19 en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):89-93. https://doi.org/10.31260/RepertMedCir.01217372.1103spa
dc.relation.referencesDíaz Pinzón, JE. Medidas de frecuencia por COVID-19 en Bogotá DC. Repert Med Cir. 2020;29(Núm. Supl.1):94-98. https://doi.org/10.31260/RepertMedCir.01217372.1110spa
dc.relation.referencesDíaz Pinzón JE. Estimación de la prevalencia del COVID-19 en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):99-102. https://doi.org/10.31260/RepertMedCir.01217372.1115spa
dc.relation.referencesMinisterio de Salud y Protección Social. Plan Nacional de vacunación contra el COVID-19 [Internet]. 2021. [Citado 10 de junio de 2021]; Disponible en: https://www.minsalud.gov.co/salud/publica/Vacunacion/Paginas/Vacunacion-covid-19.aspxspa
dc.rightsRevista Repertorio de Medicina y Cirugía - 2021spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1237spa
dc.subjectCorrelaciónspa
dc.subjectPearsonspa
dc.subjectCOVID-19spa
dc.subjectSARS-COV-2spa
dc.subjectPandemiaspa
dc.subjectVacunasspa
dc.subjectLetalidadspa
dc.titleImpacto del suministro de vacunas contra COVID-19 sobre la letalidad por SARS-COV-2 en Colombiaspa
dc.title.translatedImpacto del suministro de vacunas contra COVID-19 sobre la letalidad por SARS-COV-2 en Colombiaeng
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Colecciones

BA. Revista Repertorio